Abstract
Psychotropic medication nonadherence has significant consequences for patients, more so if they abuse substances. This descriptive study examined two stages-of-change measures: one for psychotropic medication adherence and one for substance cessation. Findings for these measures are presented for a sample of 105 patients on admission, a sample of 51 patients on 30-day follow-up, and a cohort of 39 patients who had measures for both time points. Stage advancement for dual behaviors was evident. Integrated treatment programs for this population may be further enhanced by providing interventions that promote psychotropic medication adherence.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
